Literature DB >> 2258946

Neuropathological changes and neurological function after spinal cord compression in the rat.

A Holtz1, B Nyström, B Gerdin, Y Olsson.   

Abstract

As part of a series of experimental investigations of the effects of various pharmacological agents on the outcome of compressive spinal cord trauma in the rat, the time course of the cell changes in the cord at the site of and distal to the compression was studied at the light microscopic level. The degree of compression used with the present model results in a transient paraparesis that recovers almost completely over a period of 3 weeks as judged by the inclined plane technique. The most significant morphological findings were as follows. Initially (1 and 24 h after the impact) there was pronounced swelling and hemorrhage at the compression site, chiefly in the gray matter of the cord. On day 4 there was severe necrosis in the same region, with numerous macrophages and leukocytes. Rats killed after 21 days showed either minor residual signs of necrosis or essentially normal tissue architecture. Surprisingly, necrosis with delayed onset also developed in the dorsal columns, involving the pyramidal tracts. This necrosis was detected in animals killed after 9 and 21 days but not in those observed after 4 days or earlier. The longitudinal tracts of the white matter showed reduced staining in paraffin sections of the compression site. Epon sections revealed splits in the myelin sheaths and enlarged periaxonal spaces as early as 1 h after the impact. The alterations in the longitudinal tracts persisted throughout the 21-day observation period and extended down to L2-L4. There was gradual functional recovery, documented by the inclined plane test. Preinjury values were almost reached on day 21, although the cord still showed some morphological damage. In individual animals, no relation was found between degree of function as tested by inclined plane and extent of morphologic injury. Additional functional and morphological methods obviously are needed in future investigations of the effects of treatments on the outcome of compressive spinal cord injury.

Entities:  

Mesh:

Year:  1990        PMID: 2258946     DOI: 10.1089/neu.1990.7.155

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  6 in total

1.  Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma.

Authors:  Z Li; E L Hogan; N L Banik
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

2.  Longitudinal study on diffusion tensor imaging and diffusion tensor tractography following spinal cord contusion injury in rats.

Authors:  Can Zhao; Jia-Sheng Rao; Xiao-Jiao Pei; Jian-Feng Lei; Zhan-Jing Wang; Zhao-Yang Yang; Xiao-Guang Li
Journal:  Neuroradiology       Date:  2016-03-01       Impact factor: 2.804

3.  In vivo high-resolution MR imaging of neuropathologic changes in the injured rat spinal cord.

Authors:  T Weber; M Vroemen; V Behr; T Neuberger; P Jakob; A Haase; G Schuierer; U Bogdahn; C Faber; N Weidner
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

4.  The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression.

Authors:  Natasa Jokic; Ping K Yip; Adina Michael-Titus; John V Priestley; Andrea Malaspina
Journal:  BMC Genomics       Date:  2010-11-15       Impact factor: 3.969

5.  Amitriptyline pharmacokinetics in experimental spinal cord injury in the rabbit.

Authors:  H Reihanikermani; M Ansari; A Soltani; M S Meymandi
Journal:  Indian J Pharm Sci       Date:  2008-11       Impact factor: 0.975

Review 6.  The fate of neurons after traumatic spinal cord injury in rats: A systematic review.

Authors:  Zahra Hassannejad; Shayan Abdollah Zadegan; Aida Shakouri-Motlagh; Mona Mokhatab; Motahareh Rezvan; Mahdi Sharif-Alhoseini; Farhad Shokraneh; Pouria Moshayedi; Vafa Rahimi-Movaghar
Journal:  Iran J Basic Med Sci       Date:  2018-06       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.